Record Display for the EPA National Library Catalog


OLS Field Name OLS Field Data
Main Title Malathion Exposures During Lice Treatment: Use of Exposure Related Dose Estimating Model (ERDEM) and Factors Relating to the Evaluation of Risk.
Author Power, F. W. ; Dary, C. C. ; Knaak, J. B. ; Tornero-Velez, R. ; Blancato, J. N. ;
CORP Author Environmental Protection Agency, Research Triangle Park, NC. National Exposure Research Lab.
Publisher Mar 2007
Year Published 2007
Report Number EPA/600/R-07/023; NERL-RTP-HEASD-06-173;
Stock Number PB2007-106971
Additional Subjects Pesticides ; Lice ; Malathion ; Exposures ; Treatments ; Risk evaluation ; Methods ; Metabolism ; Tissues ; Organs ; Distribution ; Chemical disposition ; Quality assurance ; Metabolites ; Scalp sizes ; Risk factors ; Children ; Pest control ; Exposure Related Dose Estimating Model (ERDEM) ; Blood partition coefficients
Library Call Number Additional Info Location Last
NTIS  PB2007-106971 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. 10/08/2007
Collation 206p
The purpose of this document is to assess the potential risk of insult and injury to children resulting from the prescribed use of malathion for the control of head lice. As required by the Food Quality Protection Act ( FQPA), the Agency has considered the pharmaceutical use of malathion in its reregistration evaluation. Ovide has been approved by the FDA for use to control a highly contagious parasite (Pediculus humanus capitis L.) that infects the human scalp. This condition is of particular importance to school age children where close human contact occurs haphazardly. The source of exposure was accordingly, the willful and prescribed use of the topical lotion, Ovide , containing 5percent (w/v) malathion (MEDICI, The Dermatology Company) lotion as a pediculicide according to label directions (The Medical Letter, 1999).